Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Central nervous system toxicity of high-dose cytosine arabinoside.

× No keyword cloud information.

8 in total

Review 1. High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors: W G Peters; L P Colly; R Willemze
Journal: Blut Date: 1988-01

Review 2. Pharmacologic strategies for the treatment of meningeal malignancy.

Authors: S M Blaney; D G Poplack
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

Review 3. Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.

Authors: H Hasle
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

Review 4. Current pharmacological treatment approaches to central nervous system leukaemia.

Authors: S M Blaney; F M Balis; D G Poplack
Journal: Drugs Date: 1991-05 Impact factor: 9.546

5. A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults.

Authors: M J Barnett; A Z Rohatiner; T S Ganesan; M A Richards; A Miller; T A Lister
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 6. Toxicity of treatment for neoplastic meningitis.

Authors: Tali Siegal
Journal: Curr Oncol Rep Date: 2003-01 Impact factor: 5.075

7. AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.

Authors: L H Lindner; H Ostermann; W Hiddemann; A Kiani; M Würfel; T Illmer; C Karsch; U Platzbecker; G Ehninger; E Schleyer
Journal: Int J Hematol Date: 2008-10-04 Impact factor: 2.490

8. Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

Authors: M Gore; R Powles; A Lakhani; S Milan; J Maitland; G Goss; A Nandi; T Perren; G Forgeson; J Treleaven
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

8 in total